1-3 of 3
Christophe de Romeuf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ublituximab, an Optimized Anti-CD20 Monoclonal Antibody, Demonstrates Greater NK-Mediated ADCC Than Rituximab in Waldenstrom's Macroglobulinemia Patients Supporting a Therapeutic Strategy with Ublituximab

Magali Le Garff-Tavernier, Linda Herbi, Christophe de Romeuf, Jean-Francois Prost, Patrice Debré, Rémi Urbain, Véronique Leblond, MD, PhD, Vincent Vieillard, Hélène Merle-Béral
Journal: Blood
Blood (2012) 120 (21): 1654.
https://doi.org/10.1182/blood.V120.21.1654.1654
Published: 2012
Journal Articles

R603: A New Low Dose Efficient Anti-CD20 Immunotherapy for CLL Patients ?

Magali Le Garff-Tavernier, Julie Decocq, Christophe de Romeuf, Jean-Luc Teillaud, Charles-Antoine Dutertre, Patrice Debre, Helene Merle-Beral, Vincent Vieillard
Journal: Blood
Blood (2008) 112 (11): 4155.
https://doi.org/10.1182/blood.V112.11.4155.4155
Published: 2008
Journal Articles

Can NK Cells Play a Role in Anti-CD20 Immunotherapy for CLL Patients?.

Magali Le Garff-Tavernier, MD, Christophe De Romeuf, PHD, Jean-Luc Teillaud, PHD, Julie Decocq, Charles-Antoine Dutertre, Patrice Debre, MD PHD, Helene Merle-Beral, MD PHD, Vincent Vieillard, PHD
Journal: Blood
Blood (2007) 110 (11): 3103.
https://doi.org/10.1182/blood.V110.11.3103.3103
Published: 2007